Guru Ownership Trend
Guru Analysis for Amicus Therapeutics, Inc. (FOLD)
Amicus Therapeutics, Inc. (FOLD), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 9 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $153.58 M.
Top institutional holders include George Soros and Steven Cohen.
Institutional sentiment is currently Bullish. This is evidenced by a $9.17 M net inflow during the quarter.
Recent activity highlights Paul Tudor Jones who increased their stake by 432.6%. Conversely, Steven Cohen reduced exposure by 71.1%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Amicus Therapeutics, Inc. (FOLD)
Major holders include George Soros ($71.2 M), Steven Cohen ($29.45 M), Renaissance Technologies (RenTech) ($17.25 M). According to the latest reported data, 9 tracked investment managers collectively hold approximately 10.62 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $9.17 M, with 6 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited FOLD. The total reported sell value was $82.87 M.
Yes, 3 managers opened new positions in FOLD, and 3 increased their existing holdings. The total reported buy value was $92.04 M.